Quick Answer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Diluted EPS of $0.01 per share for fiscal year 2013.
CTT PHARMACEUTICAL HOLDINGS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2013 | $0.01 | +109.1% |
| 2012 | -$0.11 | -127.5% |
| 2011 | $0.40 | +407.7% |
| 2010 | -$0.13 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2014 | $0.00 | +100.0% | — |
| March 31, 2014 | $0.00 | +100.0% | — |
| September 30, 2013 | $0.00 | +100.0% | +100.0% |
| June 30, 2013 | -$0.01 | — | +0.0% |
| March 31, 2013 | -$0.01 | +83.3% | +0.0% |
| September 30, 2012 | -$0.01 | +80.0% | — |
| June 30, 2012 | $0.00 | +100.0% | +100.0% |
| March 31, 2012 | -$0.06 | -109.7% | -20.0% |
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +109.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2013 period, CTT PHARMACEUTICAL HOLDINGS, INC.’s diluted eps has grown by 107.7% (from $0.13 per share (loss) to $0.01 per share).
- The most recent figure is from CTT PHARMACEUTICAL HOLDINGS, INC.’s fiscal year 2013 report (Form 10-K), filed with the SEC on February 10, 2014.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: